- Home
- ARQT vs BKE Comparison
ARQT vs BKE Comparison
Compare ARQT & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- BKE
- Stock Information
- Founded
- ARQT 2016
- BKE 1948
- Country
- ARQT United States
- BKE United States
- Employees
- ARQT N/A
- BKE N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- BKE Clothing/Shoe/Accessory Stores
- Sector
- ARQT Health Care
- BKE Consumer Discretionary
- Exchange
- ARQT Nasdaq
- BKE Nasdaq
- Market Cap
- ARQT 1.7B
- BKE 1.8B
- IPO Year
- ARQT 2020
- BKE 1992
- Fundamental
- Price
- ARQT $13.04
- BKE $42.59
- Analyst Decision
- ARQT Strong Buy
- BKE Hold
- Analyst Count
- ARQT 6
- BKE 1
- Target Price
- ARQT $18.80
- BKE $41.00
- AVG Volume (30 Days)
- ARQT 2.1M
- BKE 505.5K
- Earning Date
- ARQT 05-06-2025
- BKE 05-23-2025
- Dividend Yield
- ARQT N/A
- BKE 9.09%
- EPS Growth
- ARQT N/A
- BKE N/A
- EPS
- ARQT N/A
- BKE 3.90
- Revenue
- ARQT $212,819,000.00
- BKE $1,227,330,000.00
- Revenue This Year
- ARQT $61.15
- BKE $2.08
- Revenue Next Year
- ARQT $37.98
- BKE $2.09
- P/E Ratio
- ARQT N/A
- BKE $11.00
- Revenue Growth
- ARQT 100.03
- BKE N/A
- 52 Week Low
- ARQT $6.99
- BKE $33.12
- 52 Week High
- ARQT $17.75
- BKE $54.25
- Technical
- Relative Strength Index (RSI)
- ARQT 40.51
- BKE 67.61
- Support Level
- ARQT $13.27
- BKE $39.06
- Resistance Level
- ARQT $14.30
- BKE $43.64
- Average True Range (ATR)
- ARQT 0.71
- BKE 1.29
- MACD
- ARQT -0.07
- BKE 0.31
- Stochastic Oscillator
- ARQT 10.94
- BKE 78.96
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.